Beijing Tongren Hospital: Rhinitis, Allergic trials

The registry lists 13 Rhinitis, Allergic studies with Beijing Tongren Hospital as lead sponsor. 0 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 2 1Phase 3 2Phase 4 3No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of CM310 in Patients With Uncontrolled Seasonal Allergic RhinitisCompletedNCT05470647Phase 2
• Efficacy of Artemisia Pollen Specific Allergen ImmunotherapyStatus unknownNCT05318157Phase 4
• Early Intervention in Allergic PatientsCompletedNCT05040828Phase 4
• Novel Dose Adjustment Schedule for Late Injection in SCIT in ARCompletedNCT04929093Phase 4
• The Efficacy of Preseasonal Omalizumab TreatmentCompletedNCT04489121Not applicable
• Efficacy, Safety and Underlying Mechanisms of Sphenopalatine Ganglion Acupuncture for Perennial Allergic RhinitisStatus unknownNCT04234451Not applicable
• Compare the Effect of INS Alone and Added LTRA in Treatment of SARCompletedNCT04077892Early Phase 1
• Efficacy, Safety and Underlying Mechanisms of Sphenopalatine Ganglion Acupuncture for Seasonal Allergic RhinitisStatus unknownNCT04052945Not applicable
• Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia AnnuaCompletedNCT03990272Phase 3
• Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic RhinitisCompletedNCT03649139Phase 3
• The Effects of Sphenopalatine Ganglion Acupuncture in Patients With Seasonal Allergic RhinitisCompletedNCT03282630Not applicable
• Interaction Effect of Asthma and Aeroallergen Category on the Psychological Status in Allergic Rhinitis PatientsCompletedNCT01295255
• Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis ChildrenCompletedNCT01291381Not applicable